President Donald Trump's pick for surgeon general, wellness influencer and Robert F. Kennedy Jr.-ally Casey Means, is big ...

Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...

Hospitalized children who have an underlying condition other than asthma or who have reactive airway disease are at higher ...

Peter Marks, the venerable head of the FDA’s Center for Biologics Evaluation and Research, has been forced out. In this ...

Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S.

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

The Cambridge-based company says the vaccine is at least as good as getting both vaccines separately, it will seek FDA ...

M spin-off Solventum beat analysts' estimate for first-quarter profit on Thursday, helped by higher sales of its wound care, sterilization products.

A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...

FDA commissioner Marty Makary told FDA staff in an email that Prasad, “brings a great set of skills, energy, and competence ...